Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

Geron Corporation (NASDAQ:GERN) on June 12 announced that the U.S. Food and Drug Administration (FDA) has removed the partial clinical hold on the investigator-sponsored clinical trial of imetelstat in myelofibrosis (Myelofibrosis IST). The partial clinical hold was placed in March 2014 due to a safety signal of hepatotoxicity that was identified in clinical trials of imetelstat. Geron Corporation (NASDAQ:GERN) stock performance was 4.01% in last … Continue reading Biotech Movers: Geron Corporation (NASDAQ:GERN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Ariad Pharmaceuticals, Inc. (NASDAQ:ARIA), AVEO Pharmaceuticals, Inc. (NASDAQ:AVEO), Gilead Sciences (NASDAQ:GILD)

Active Movers: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Groupon Inc (NASDAQ:GRPN), Twenty-First Century Fox Inc (NASDAQ:FOXA), Sirius XM Holdings Inc. (NASDAQ:SIRI), DryShips Inc. (NASDAQ:DRYS)

The U.S. drug maker offered Idenix Pharmaceuticals Inc. (NASDAQ:IDIX) shareholders $24.50 a share, or $3.85 billion, for the developer of hepatitis C drugs. That’s almost quadruple the stock’s average unaffected price over the previous 20 days, the highest premium on record for any health care deal of at least $100 million, according to data compiled by Bloomberg. Idenix Pharmaceuticals Inc (NASDAQ:IDIX) stock performance was -0.55% … Continue reading Active Movers: Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Groupon Inc (NASDAQ:GRPN), Twenty-First Century Fox Inc (NASDAQ:FOXA), Sirius XM Holdings Inc. (NASDAQ:SIRI), DryShips Inc. (NASDAQ:DRYS)

Mark Zuckerberg and other members of Facebook Inc (NASDAQ:FB)’s board have been sued by a shareholder who claimed a policy letting them annually award directors more than $150 million of stock each if they choose is unreasonably generous. Facebook Inc (NASDAQ:FB) stock performance was 0.61% in last session and finished the day at $62.88. Traded volume was 37.62million shares in the last session and the … Continue reading Active Movers: Facebook Inc (NASDAQ:FB), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), Sirius XM Holdings Inc. (NASDAQ:SIRI), General Electric Company (NYSE:GE)

AbbVie may now consider a takeover of Achillion Pharmaceuticals Inc. (NASDAQ:ACHN), a $411 million company, to expand in that market, Redmond said. Shares of Achillion rallied (ACHN:US) as much as 67 percent yesterday. Achillion Pharmaceuticals, Inc. (NASDAQ:ACHN) stock performance was 47.57% in last session and finished the day at $4.25. Traded volume was 47.79million shares in the last session and the average volume of the … Continue reading Biotech unusual volume stocks: Achillion Pharmaceuticals (NASDAQ:ACHN), Idenix Pharmaceuticals Inc (NASDAQ:IDIX), BioDelivery Sciences International (NASDAQ:BDSI), ImmunoCellular Therapeutics (NYSEMKT:IMUC), Anika Therapeutics (NASDAQ:ANIK)

Aastrom Biosciences Inc (NASDAQ:ASTM) posted its quarterly earnings results on Thursday. The company reported ($1.26) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.92) by $0.34, AnalystRatings.NET reports. On a related note, analysts at Zacks reiterated a “neutral” rating on shares of the company in a research note on Friday, March 14th. They now have a $5.00 price target on the … Continue reading Biotech Volatile Stocks: Aastrom Biosciences Inc (NASDAQ:ASTM), Puma Biotechnology Inc (NYSE:PBYI), Oncolytics Biotech (NASDAQ:ONCY), Clovis Oncology (NASDAQ:CLVS), Idenix Pharmaceuticals (NASDAQ:IDIX)